catalent News

Catalent scientist and manager of Viral Clearance and Safety, Hazel Aranha, Ph.D., will have a prominent role in leading this year’s Viral Safety for Biologicals workshop held at the Angelo Hotel in Prague, Czech Republic on May 10-11, 2011.

Catalent Pharma Solutions, a leading provider of pharmaceutical services from drug and biologic development to delivery technologies to supply solutions, has announced three new appointments to its Development and Clinical Services business unit.

Carolyn Finkle, Vice President of Regulatory Consulting for North America at Catalent Pharma Solutions will have a leading role in this year’s Pharmaceutical Education and Research Institute.

Alan Hendricker, Ph.D., Principal Scientist of Structural Chemistry, and Thomas Feinberg, Ph.D., Director of Structural Chemistry, at Catalent Pharma Solutions will have prominent roles at this year’s PQRI workshop.

Catalent Pharma Solutions will host an educational webinar featuring the Optiform™ Technologies team of Catalent experts: Dr. Joanna Bis, Dr. Pingyun Chen, and Dr. David Igo.

Global Network of Specialists Enhances Its Full Range of Clinical Supply Services to Ensure Reliable Supply, Timely Delivery and Competitive Pricing for Comparator Drug Sourcing

Catalent Pharma Solutions announces the installation of electronic verification applications at its Clinical Supply Services facilities in Philadelphia, PA and Schorndorf, Germany.

Kent M. Payne, Ph. D., Vice President and General Manager of Respiratory, Analytical and Biotechnology at Catalent Pharma Solutions, presented “Visualizing Customer Delivery” at the 26th Annual AME Conference in Baltimore, Maryland.

Catalent Pharma Solutions announced an expansion of its development capabilities for oral controlled release dosage forms.

Catalent Pharma Solutions, LLC has added the Xcelodose® micro-dosing system to its Research Triangle Park (RTP), North Carolina facility.

Leading scientists from Catalent Pharma Solutions will be presenting six scientific poster papers along with leading a mini-symposium at the Annual American Association of Pharmaceutical Scientists (AAPS) meeting (November 15-17 in New Orleans, LA).

Catalent Pharma Solutions has won for the third year in a row “The Best Contract Manufacturing Project” award at the 2010 European Outsourcing Awards, again recognizing its industry leadership and excellence.

Mark Dean-Netscher, Vice President Operations Europe for Catalent Pharma Solutions, will lead a workshop “Sustaining Improvement Initiatives in Pharmaceutical and Consumer Goods Sector,” at the Next Generation Pharma Manufacturing Summit 2010.

Julien Meissonnier, Director of R&D for Catalent Pharma Solutions in Beinheim, France, has been appointed to the Board of Directors of the Alsace BioValley, the cluster for life sciences and healthcare in France.

Catalent Softgel Expert to Present on Bioavailability Improvement at the 3rd Annual Drug Repositioning and R&D Enhancement Conference

The Optiform™ compound optimization platform, a novel, solid-state and highly-automated analysis platform for salt, crystal-form, and co-crystal screening, will now be broadly available to early development scientists for the first time.

Corinne Mounier-Lee, Ph.D., Principal Scientist at Catalent Pharma Solutions, will deliver a presentation at CBI/IVT’s 7th Annual Method Validation Conference, July 28-30, 2010 in San Francisco, CA.

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, has been invited by the Taiwan Biotech Organization to lead a one-day workshop on GMP Bioassay Validation and GLP Immunogenicity Method Development.

Dr. Craig J. Davies-Cutting will deliver a presentation titled, “Considerations and Approaches for Filling Dry Powder Inhalers (DPIs)” at the Management Forum Conference on Dry Powder Inhalers in London, UK.

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent, will be leading an interactive pre-conference workshop titled, “Immunogenicity Programs: Not Just Another Box to Check” at the 6th Annual Global Proteins Summit in London, UK.

Catalent Pharma Solutions’ industry experts will deliver scientific poster presentations this month at the 2010 AAPS National Biotechnology Conference, May 16-19 in San Francisco, California.

Alan Hendricker, Ph.D. will be lead a discussion titled, “Migration Study Design and Case Study of Benzophenone Leaching from Packaging Componentry into Drug Product Solution” during PharmaED’s Extractables and Leachables 2010 Conference.

Catalent Pharma Solutions’ industry experts will deliver scientific poster presentations this week at Respiratory Drug Delivery (RDD) 2010, April 25-29 in Orlando, Florida.

At a time when melamine-contamination has received global attention, Catalent Pharma Solutions continues its legacy of innovation by rapidly developing new FDA guidance-compliant tests for trace amounts of key contaminants in food and medicine.

Biotech Vendor Services, Inc. (BVS) is pleased to announce that our much anticipated “La Jolla Drug Development Day” will take place on Wednesday, July 22 at the Hyatt Regency Hotel in La Jolla, California.

An article co-authored by Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, has been selected for the 2008 Jack L. Beal Award.

Michael Jenkins, PhD, general manager of Catalent’s Middleton, WI facility, will present at the BIO Process Theatre of the 2009 BIO International Convention. His talk will focus on Catalent’s GPEx technology for mammalian cell line engineering.

Two Catalent scientists, Dr. Tom Feinberg, director of structural chemistry services, and Dr. Craig Davies-Cutting, director of research and development, will host a 45-minute interactive workshop at RDD Europe 2009.

Dr. Hans Westenburg, a senior scientist of structural characterization and analysis at Catalent Pharma Solutions, will present this month at the TIDES 2009 Conference to be held in Las Vegas, NV, May 17-20, 2009.

An article written by Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, was featured in the Biotechnology Industry Organization’s (BIO) March 2009 e-Newsletter and is available for download @ www.bio.org.

Ana T. Menendez, Ph.D., Senior Director of Biotechnology at Catalent Pharma Solutions, will be teaching a course titled "Bioassay Method Development and Validation" on April 2-3 in San Francisco for IBC Life Sciences.

Michael Barron, MBA, Account Director at Catalent Pharma Solutions, will be a presenter at The Center for Business Intelligence’s (CBI) 2nd Annual Conference on Comparator Studies on March 26-27, 2009 in Philadelphia, P.A.

Catalent Pharma Solutions, a worldwide leading provider of advanced technologies for pharmaceutical, biotechnology and consumer health companies, will be featured in the upcoming April edition of Journal of Pharmaceutical Research.

Account Director at Catalent Pharma Solutions will discuss the selection of sterilization and drying processes for rubber stoppers on injectable packaging.

Two members of Catalent's Respiratory, Analytical and Biotechnology Group will participate in the Parenteral Drug Association West Coast Chapter’s panel discussion titled “Challenges and Best Practices in Extractable and Leachables.”

Dr. Greg Bleck, the senior director of cell line engineering at Catalent Pharma Solutions, will present at the 12th Annual Pep Talk 2009 Protein Expression Conference to be held in San Diego, C.A., January 12-14, 2009.

Greg Bleck, the senior director of cell line engineering at Catalent Pharma Solutions, will present this week at the 2nd International Cell Engineering Conference to be held in Santa Barbara, C.A., December 2-4, 2008.

Catalent’s Respiratory, Analytical and Biotechnology Group will be well represented at this year’s American Association of Pharmaceutical Scientists Annual Meeting with a number of its team members conducting scientific poster presentations.